BOSTON SCIENTIFIC CORP — Director's Dealing 2015

Jan 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-01-01

Reporting Person: Phalen Michael P. (EVP & President, MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-01	Common Stock	M	41401.0000	$0.0000	Acquired	170046.0000	Direct
2015-01-01	Common Stock	F	13812.0000	$13.2500	Disposed	156234.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-01	Performance Share Units	$	M	41401.0000	Disposed	2014-12-31	Common Stock (41401.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2433.0000	Indirect

Footnotes

F1: On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2014.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Each performance share unit represented the Company's commitment to issue one share of Boston Scientific common stock.